Well the unique strain of plant is what leads to the different constituents. I'm not sure how the trial design would lead to epigenetic changes without it being the extract, as everything else is mostly observational and from questions. Obviously epigenetic changes could take place due to another changed environmental factor, including seasonal change, but it would seem to be a great coincidence.
There's always a chance of a clinical stuff up, but usually these stuff ups are random.
Serping1 - something I am interested in looking into, when I am not distracted.
Overall taken at face value - item 3 is potentially profound! If NTI164 has flipped epigenetic switches in a favorable way, you would expect binary outcomes. It may be that there are other conditions outside what NTI is looking at, that would benefit from that as well.
- Forums
- ASX - By Stock
- NTI
- Ann: NTI164 Reverses Immune Dysregulation in PANDAS/PANS Children
Ann: NTI164 Reverses Immune Dysregulation in PANDAS/PANS Children, page-10
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.1¢ |
Change
-0.001(1.92%) |
Mkt cap ! $52.76M |
Open | High | Low | Value | Volume |
5.1¢ | 5.1¢ | 5.0¢ | $47.84K | 954.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 291484 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 399999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 278484 | 0.050 |
4 | 667309 | 0.049 |
5 | 312000 | 0.048 |
3 | 1158000 | 0.047 |
2 | 1705152 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 399999 | 1 |
0.052 | 68654 | 2 |
0.053 | 258420 | 4 |
0.056 | 95800 | 1 |
0.057 | 80000 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |